Monte Rosa Therapeutics Cash Flow Statement (2020-2026) | GLUE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-18.11M	-19.86M	-23.37M	-24.15M	-26.47M	-27.32M	-30.78M	-32.04M	-35.18M	-34.88M	-33.25M	-31.97M	-30.31M	-23.86M	13.44M	46.88M	-12.29M	-27.08M	-29.49M	-44.50M
Depreciation and Depletion (Quarter)	0.40M	0.60M	0.81M	0.80M	0.89M	1.03M	1.02M	1.20M	1.39M	1.83M	1.82M	1.90M	2.06M	2.10M	2.06M	2.00M	2.12M	2.10M	2.09M	2.03M
Share-based Compensation (Quarter)	1.02M	2.07M	1.86M	2.25M	2.87M	3.21M	3.33M	3.97M	4.15M	4.47M	4.07M	4.87M	4.50M	4.28M	4.47M	5.30M	4.89M	4.36M	4.31M	5.95M
Gains from Sales and Divestitures (Quarter)	0.07M	0.20M	0.24M	0.03M	0.07M	0.10M	0.14M	0.03M	0.07M	0.04M	0.04M	0.00M	0.01M	0.12M	0.12M		0.11M	0.11M	0.11M	0.19M
Gains from Investment Securities (Quarter)	0.37M	0.37M	-0.00M	0.12M	0.14M	1.95M	0.11M	-0.13M	2.94M	0.64M			11.54M	11.59M		3.57M	3.81M	3.84M
Non-cash Items (Quarter)	0.04M	82.19M	70.05M	40.52M	1.72M	14.90M	12.44M	3.12M	9.29M	3.70M	4.74M	4.99M	1.84M	4.12M	11.42M	7.48M	8.08M	8.48M	115.25M	122.64M
Cash from Operations (Quarter)	-13.58M	-17.79M	-14.17M	-27.40M	-20.50M	-20.60M	-23.96M	-23.41M	-25.32M	-24.71M	29.63M	-38.16M	-27.77M	-20.99M	128.92M	-45.49M	-34.72M	100.43M	-43.01M	-37.37M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)	0.40M	0.60M	0.81M	0.80M	0.89M	1.03M	1.02M	1.20M	1.39M	1.83M	1.82M	1.90M	2.06M	2.10M	2.06M	2.00M	2.12M	2.10M	2.09M	2.03M
Change in Working Capital
Change in Receivables (Quarter)						0.18M	0.01M	-2.05M	0.20M	-0.38M	0.34M	0.01M	0.33M	-0.25M	-0.42M	1.24M	0.96M	2.60M	-0.36M	0.01M
Change in Account Payables (Quarter)	-0.29M	-4.25M	4.74M	-2.18M	-0.36M	1.65M	0.15M	0.31M	-1.00M	0.69M	5.77M	-5.07M	0.39M	-2.38M	13.31M	-10.87M	-1.10M	8.88M	-10.61M	4.38M
Change in Accured Expenses (Quarter)	1.58M	5.88M	-0.14M	-3.56M	1.36M	1.16M	2.07M	-3.29M	2.77M	2.79M	1.29M	-3.89M	2.04M	2.33M	3.70M	-2.61M	-2.47M	4.19M	8.73M	-3.71M
Other Working Capital Changes (Quarter)	-0.66M	2.26M	-1.59M	-0.38M	0.30M	0.05M	-0.16M	6.89M	-6.89M		-1.08M	2.29M	0.12M	2.53M	78.44M	-0.28M	2.00M	-2.49M	0.18M	2.92M
Investing Activities
Capital Expenditures (Quarter)	-2.09M	6.55M	3.06M	1.69M	2.55M	0.51M	8.16M	4.40M	11.29M	1.66M	-17.11M	0.98M	2.42M	0.40M	-3.75M	0.30M	2.98M	0.65M	-3.78M	1.87M
Sales of Property, Plant and Equipment (Quarter)			0.01M	0.12M		-0.02M			0.06M
Change in Acquisitions & Divestments (Quarter)								45.63M
Cash from Investing Activities (Quarter)	-2.70M	-1.69M	-3.05M	-180.52M	-14.25M	29.49M	-53.94M	20.33M	18.55M	35.63M	14.30M	9.85M	-61.16M	37.75M	-30.90M	-100.23M	25.32M	38.14M	-65.07M	-261.00M
Financing Activities
Other financing activities (Quarter)	18.50M	2.30M	-0.23M			0.71M	0.34M				0.28M				0.23M
Cash from Financing Activities (Quarter)	205.47M	29.46M	-0.14M	0.15M	0.10M	-0.22M	20.43M	0.02M	1.20M	1.10M	25.17M	0.25M	98.02M	0.01M	0.61M	0.01M	0.36M	0.35M	29.62M	328.33M
Additional items
Change in Cash (Quarter)	189.19M	9.97M	-17.35M	-207.77M	-34.65M	8.67M	-57.47M	-3.06M	-5.57M	12.02M	69.10M	-28.07M	9.10M	16.77M	98.63M	-145.71M	-9.03M	138.91M	-78.46M	29.97M
Free Cash Flow (Quarter)	-11.49M	-24.34M	-17.23M	-29.09M	-23.05M	-21.11M	-32.12M	-27.81M	-36.62M	-26.36M	46.75M	-39.15M	-30.19M	-21.39M	132.68M	-45.80M	-37.70M	99.78M	-39.23M	-39.24M
Net Cash Flow (Quarter)	189.19M	9.97M	-17.35M	-207.77M	-34.65M	8.67M	-57.47M	-3.06M	-5.57M	12.02M	69.10M	-28.07M	9.10M	16.77M	98.63M	-145.71M	-9.03M	138.91M	-78.46M	29.97M

Research Tools

Developers

Monte Rosa Therapeutics Cash Flow Statement (2020-2026) | GLUE

Research Tools

Developers

Monte Rosa Therapeutics Cash Flow Statement (2020-2026) | GLUE

Create an account

Sign In

Reset Password